KRAS

You have access
CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in KRAS Mutant Cholangiocarcinoma Cell Lines
DA SOL LEE, MIN WOO HAN, YONGHYUN KANG, CHORONG KIM, SEONMIN LEE, KYU-PYO KIM and CHANGHOON YOO

Anticancer Research May 2024, 44 (5) 1939-1946; DOI: https://doi.org/10.21873/anticanres.16996
You have access
PHRF1 Promotes Cell Invasion by Modulating SOX4 Expression in Colorectal Cancer HCT116-p53^−/− Cells
HUNG-WEI LIN, TING-WEI SHIH, ADAOBI AMANNA and MAU-SUN CHANG

Anticancer Research December 2023, 43 (12) 5437-5446; DOI: https://doi.org/10.21873/anticanres.16747
Open Access
Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS^G12D Inhibitor, in Colorectal Cancer Treatment
MASAHIRO KATAOKA, MASATO KITAZAWA, SATOSHI NAKAMURA, MAKOTO KOYAMA, YUTA YAMAMOTO, SATORU MIYAZAKI, NAO HONDO, HIROKAZU TANAKA and YUJI SOEJIMA

Anticancer Research October 2023, 43 (10) 4341-4348; DOI: https://doi.org/10.21873/anticanres.16629
Open Access
Prognostic Value of KRAS Exon-specific Mutations in Patients With Colorectal Cancer
KENTARO ASAKO, TAMURO HAYAMA, YOJIRO HASHIGUCHI, TOSHIYA MIYATA, YOSHIHISA FUKUSHIMA, RYU SHIMADA, KENSUKE KANEKO, KEIJIRO NOZAWA, KEIJI MATSUDA and TAKEO FUKAGAWA

Anticancer Research April 2023, 43 (4) 1563-1568; DOI: https://doi.org/10.21873/anticanres.16306
Open Access
Cancer Spheroid Proliferation Is Suppressed by a Novel Low-toxicity Compound, Pyra-Metho-Carnil, in a Context-independent Manner
KAZUMASA YOSHIDA, KENSUKE NISHI, SHUHEI ISHIKURA, KAZUHIKO NAKABAYASHI, RYO YAZAKI, TAKASHI OHSHIMA, MASAHIKO SUENAGA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA

Anticancer Research August 2022, 42 (8) 3993-4001; DOI: https://doi.org/10.21873/anticanres.15895
You have access
Growth Suppression of Cancer Spheroids With Mutated KRAS by Low-toxicity Compounds from Natural Products
SAYURI HASHIMOTO, MASAYOSHI NAGAI, KENSUKE NISHI, SHUHEI ISHIKURA, KAZUHIKO NAKABAYASHI, RYO YAZAKI, TAKASHI OHSHIMA, MASAHIKO SUENAGA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA

Anticancer Research August 2021, 41 (8) 4061-4070; DOI: https://doi.org/10.21873/anticanres.15207
You have access
Radiogenomic and Deep Learning Network Approaches to Predict KRAS Mutation from Radiotherapy Plan CT
BUM-SUP JANG, CHANGHOON SONG, SUNG-BUM KANG and JAE-SUNG KIM

Anticancer Research August 2021, 41 (8) 3969-3976; DOI: https://doi.org/10.21873/anticanres.15193
You have access
Mutant KRAS Promotes NKG2D⁺ T Cell Infiltration and CD155 Dependent Immune Evasion
KENSUKE NISHI, SHUHEI ISHIKURA, MASAYO UMEBAYASHI, TAKASHI MORISAKI, TAKASHI INOZUME, TETSUSHI KINUGASA, MIKIKO AOKI, SATOSHI NIMURA, ANTHONY SWAIN, YOICHIRO YOSHIDA, SUGURU HASEGAWA, KAZUKI NABESHIMA, TOSHIFUMI SAKATA, SENJI SHIRASAWA and TOSHIYUKI TSUNODA

Anticancer Research August 2020, 40 (8) 4663-4674; DOI: https://doi.org/10.21873/anticanres.14465
You have access
MK615 Suppresses Hypoxia Tolerance by Up-regulation of E-cadherin in Colorectal Cancer Cells With Mutant KRAS
KENSUKE NISHI, TOSHIYUKI TSUNODA, YOSHINORI UCHIDA, TAKAYUKI SUETA, MOTOHIRO SAWATSUBASHI, TAKAFUMI YAMANO, YASUKO HASHIGUCHI, ANTHONY SWAIN, SENJI SHIRASAWA and TOSHIFUMI SAKATA

Anticancer Research August 2020, 40 (8) 4687-4694; DOI: https://doi.org/10.21873/anticanres.14468
You have access
Secretin-induced Duodenal Aspirate of Pancreatic Juice (SIDA): Utility of Commercial Genetic Analysis
RACHEL E. SIMPSON, MICHELE YIP-SCHNEIDER, KATELYN F. FLICK, MAZHAR SOUFI, EUGENE P. CEPPA, MOHAMMAD A. AL-HADDAD, JEFFREY J. EASLER, STUART SHERMAN, JOHN M. DEWITT and C. MAX SCHMIDT

Anticancer Research August 2020, 40 (8) 4215-4221; DOI: https://doi.org/10.21873/anticanres.14422

Main menu

User menu

Search

KRAS

Pages